Article Detail - JE Part A
Notice: Allergy Immunotherapy Claims for Venom Allergies
Overview
This bulletin provides clarification regarding claims processing for Allergy Immunotherapy services furnished for the treatment of venom allergies following implementation of the Allergy Immunotherapy Local Coverage Determination (LCD) and associated Billing and Coding Article, effective October 26, 2025.
Background
The Allergy Immunotherapy LCD establishes coverage criteria for immunotherapy services used in the treatment of allergies to aeroallergens, including inhaled allergens such as pollens, dust mites, and animal dander.
Allergy immunotherapy, including subcutaneous immunotherapy (SCIT), administered for non-aeroallergens—such as venoms—is not included within the scope of this LCD. Claims for venom allergy immunotherapy are therefore processed outside the provisions of the Allergy Immunotherapy LCD.
Current Status
An issue has been identified in the claims processing of AIT for treatment of venom allergy. Noridian is updating internal claims processing systems to ensure appropriate handling of these claims moving forward.
Provider Action
Providers are asked to allow approximately 4 weeks for these claims processing system updates to be completed. Following this timeframe, any new claims moving forward will process accordingly; and to ensure previously affected claims are addressed, we are asking providers to resubmit venom allergy immunotherapy claims for re-processing.
Noridian thanks you for your patience.
Additional Information
Further updates will be communicated as appropriate.
